Check out what we have in store for you in the July Mid-Month Newsletter
Hepatitis C: The Problem with Numbers
by Alan Franciscus, Editor-in-Chief
In this article, I will discuss the published numbers of acute and chronic HCV and what some experts believe is a better estimate of the number of acute, chronic and annual deaths caused by hepatitis C.
The Five: The Next HCV Drugs
by Alan Franciscus, Editor-in-Chief
This month’s “The Five” will discuss the most promising drugs in development, including a couple of combinations of drugs submitted to, and likely to be approved by, the Food and Drug Administration (FDA) by the end of this year or early next year.
Disability & Benefits: Medicare at Age 65
by Jacques Chambers, CLU
Unlike those on SSD who are enrolled automatically in Parts A & B of Medicare, people turning age 65 must actively choose whether or not to enroll in Medicare in addition to deciding which parts are appropriate for them. As well you must enroll in Medicare at the appropriate times or penalty surcharges can be added to the premiums, and they will last as long as you are on Medicare.
Snapshots
by Alan Franciscus, Editor-in-Chief
This month’s column discusses hepatitis C interferon-free regimes in the elderly, and hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir.
What’s New! Updated Easy C Facts
by Alan Franciscus, Editor-in-Chief
Schedule for Hepatitis C Training Workshops
Check out if one of our trainings will take place near you!
Click here to read this issue:
Share This Page
Follow Us